In doing so, they will be guided by one central question: how might a drug - based treatment
target the gene responsible for the release of fatty acids and the enzyme ATGL, and how might it do so exclusively in adipose tissue?
Now, the team has found that another type of dwarf phage also
targets a gene responsible for a cell wall - building enzyme.
Not exact matches
If we know which
genes are
responsible for breast cancer, then we can tailor therapies to
target those
genes specifically.»
To validate their findings, the scientists injected the novel nanoparticles into pancreatic tumor - bearing mice and observed that by balancing these two
targets — bringing them to a normal level by increasing their expression or blocking the
gene responsible for their expression — they significantly prolonged the survival of the mice.
Still, the standard form of liver -
targeted gene therapy carries a range of potential complications, including the risk of harmful mutations and of the body mounting an immune response against the viral vectors used to carry the correct forms of the defective
genes responsible for haemophilia.
«We are currently identifying the
genes responsible for generating the DNA tether, which could be promising novel
targets for the next generation of cancer therapies.»
Utilizing genetic approaches such as «fine mapping» and «genome editing,» the researchers narrowed the region of the chromosome and
targeted each
gene to
responsible for affecting the behavioral response to the drug.
Vaxwave ® is based on lymphocytic choriomeningitis virus (LCMV) and in this vector the
gene encoding the LCMV envelope protein, normally
responsible for virus entry into
target cells, has been deleted and replaced with a
target gene of interest.
«Using a clinically tested
gene therapy platform, we are able to induce very specific regulatory cells that
target the self - reactive cells that are
responsible for causing multiple sclerosis,» says Brad E. Hoffman, co-author of the study.
Published in Science, an exciting paper describes a new CRISPR - based
gene editing system that
targets RNA, the molecule
responsible for translating DNA into protein, instead of DNA.
We hypothesized that antimicrobial resistance can be reversed by
targeting chromosomal non-essential
genes that are not
responsible for acquired resistance but essential for resistant bacteria under therapeutic concentrations of antimicrobials.
The drug, named Inclisiran, utilizes a technique called RNA interference therapy which
targets, and switches off, a specific
gene known to be
responsible for elevated LDL levels.